JPM
JPMorgan Chase & Co.
JPM's fundamentals are strong, but it looks expensive: trading at 14x earnings, above its usual 12x. Analysts expect earnings growth.
SPLS
PIMCO US Stocks PLUS Active Bond Exchange Traded Fund
There isn't enough reported data to score SPLS yet.
JPM Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| N/A | |
| N/A |
JPM's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like JPM.
SPLS Fundamentals
| Metric | Status |
|---|---|
| Unavailable | |
| Healthy | |
| N/A | |
| N/A |
SPLS's profitability is currently healthy. There isn't enough data to rate its revenue. Free cash flow and net leverage aren't meaningful measures for financial services companies like SPLS.
JPM PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 9.7x | $231 | -33% |
| Fair | 12x | $287 | -16% |
| Current | 14x | $343 | โ |
| Forward | 14x | $343 | โ |
| Expensive | 15x | $361 | +5.2% |
Historical ranges are pointers, not guarantees.
JPM's PE is in its expensive range at 14.4x. If earnings grow as analysts expect, today's price would be 13.7x next year's earnings.
SPLS PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 84x | $54.42 | -0.5% |
| Current | 84x | $54.70 | โ |
| Fair | 85x | $55.09 | +0.7% |
| Expensive | 85x | $55.47 | +1.4% |
Historical ranges are pointers, not guarantees.
SPLS has the edge over JPM in the historical PE scenario, which offers more potential upside but is not a forecast.
JPM Forward outlook
| Metric | Outlook |
|---|---|
| Stable | |
| Growth | |
| Growth | |
| Improving | |
| Limited | |
| Moderate |
Analysts expect earnings and revenue growth for JPM, with profitability improving.
SPLS Forward outlook
There aren't enough analyst estimates for SPLS to show an outlook.
JPM Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $24.99 | +4.8% |
| Q3 2026 | $23.85 | +18% |
| Q2 2026 | $23.35 | +20% |
| Q1 2026 | $20.89 | +2.5% |
| Q4 2025 | $20.02 | +1.4% |
| Q3 2025 | $20.20 | +12% |
| Q2 2025 | $19.50 | +8.7% |
| Q1 2025 | $20.38 | +23% |
| Q4 2024 | $19.75 | +22% |
JPM has the stronger earnings trend. Trailing diluted EPS is up 18% for JPM versus SPLS down 21%.
SPLS Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2014 | $0.82 | +$1.11 |
| Q2 2014 | $0.85 | +$1.12 |
| Q1 2014 | $0.96 | +$1.22 |
| Q4 2013 | $0.75 | +2400% |
| Q3 2013 | -$0.29 | -122% |
| Q2 2013 | -$0.27 | -119% |
| Q1 2013 | -$0.26 | -118% |
| Q4 2012 | $0.03 | -98% |
SPLS's earnings per share have fallen from their peak: $0.65 over the past year, against $1.41 in early 2012.
JPM Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $50.2B | +8.1% |
| Q2 2026 | $57.3B | +28% |
| Q1 2026 | $49.8B | +10% |
| Q4 2025 | $45.8B | +7.1% |
| Q3 2025 | $46.4B | +8.8% |
| Q2 2025 | $44.9B | -11% |
| Q1 2025 | $45.3B | +8.1% |
| Q4 2024 | $42.8B | +11% |
JPM has the stronger quarterly revenue trend. Revenue is up 8.1% for JPM versus down 18% for SPLS.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 40% | -0.2 points |
| Q2 2026 | 48% | +7.3 points |
| Q1 2026 | 41% | +0.5 points |
| Q4 2025 | 37% | -3.2 points |
| Q3 2025 | 40% | +0.6 points |
| Q2 2025 | 41% | -6 points |
| Q1 2025 | 41% | -0.6 points |
| Q4 2024 | 41% | +11 points |
JPM's operating margin was 40% last quarter, about level with the same quarter a year ago.
SPLS Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2017 | $3.9B | -18% |
| Q2 2017 | $4.1B | -19% |
| Q1 2017 | $3B | -42% |
| Q3 2016 | $4.8B | -3.7% |
| Q2 2016 | $5.1B | -3.1% |
| Q1 2016 | $5.3B | -6.9% |
| Q3 2015 | $4.9B | -5.4% |
| Q2 2015 | $5.3B | -6.9% |
SPLS's revenue has slid since its 2011 peak: $3.9B last quarter, down 18% from the same quarter a year ago.
JPM Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $33.2B | +$78.4B |
| Q2 2026 | -$25.3B | -186% |
| Q1 2026 | -$211.8B | +$40.1B |
| Q4 2025 | $119.7B | -19% |
| Q3 2025 | -$45.2B | +$28.9B |
| Q2 2025 | $29.5B | -23% |
| Q1 2025 | -$251.8B | -$97.7B |
| Q4 2024 | $147.8B | +145% |
SPLS has the stronger cash trend. Its trailing FCF is up 31% versus its history, compared with JPM at down 229%.
SPLS Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2017 | -$31M | +$314M |
| Q2 2017 | $221M | -4.7% |
| Q1 2017 | $207M | +90% |
| Q3 2016 | -$345M | -$267M |
| Q2 2016 | $232M | -3.3% |
| Q1 2016 | $109M | +$134M |
| Q3 2015 | -$78M | +$40M |
| Q2 2015 | $240M | -23% |
SPLS's free cash flow was $982M over the past year, against โ$82M the year before. Free cash flow isn't a meaningful measure for financial services companies like SPLS.
JPM Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.5x | Very low |
| Q2 2026 | 0.5x | Very low |
| Q1 2026 | 0.6x | Very low |
| Q4 2025 | 0.5x | Very low |
| Q3 2025 | 0.6x | Very low |
| Q2 2025 | 0.5x | Very low |
| Q1 2025 | 0.5x | Very low |
| Q4 2024 | 0.4x | Very low |
JPM's net debt is less than a year of its operating earnings (EBITDA). Net leverage isn't a meaningful measure for financial services companies like JPM.
SPLS Net Leverage
JPM Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 54.8 | Neutral |
| Stochastic | 31.5 | Neutral |
JPM's weekly RSI is 55 (neutral) and its Stochastic is 31 (neutral).
SPLS Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 66.6 | Neutral |
| Stochastic | 31.7 | Neutral |
SPLS's weekly RSI is 67 (neutral) and its Stochastic is 32 (neutral).
JPM PE vs Financial Services Sector
| Metric | JPM | Sector median | Relative |
|---|---|---|---|
| PE | 14x | 13x | 10% above |
| PE % | 76 | 63 | 13 pts above |
JPM has the edge over SPLS on valuation relative to its sector.
SPLS PE vs Financial Services Sector
| Metric | SPLS | Sector median | Relative |
|---|---|---|---|
| PE | 84x | 13x | 543% above |
SPLS is trading at 84x earnings, a 543% premium to the Financial Services sector's median of 13x, though its earnings don't support one.
JPM Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $336.8 | 1.8% above |
| 20 week MA | $345.3 | 0.7% below |
| 50 week MA | $323.2 | 6.1% above |
| 100 week MA | $298.9 | 15% above |
| 200 week MA | $236.6 | 45% above |
JPM has stronger trend alignment. JPM is above 4 of 5 weekly averages versus SPLS above 2 of 4.
SPLS Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $54.9 | 0.4% below |
| 20 week MA | $55.0 | 0.5% below |
| 50 week MA | $39.0 | 40% above |
| 100 week MA | $24.0 | 128% above |
SPLS has pulled back, but its long-term trend is still up: it's below its 8- and 20-week averages, but 128% above its 100-week average.
JPM Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $139.1 | $124.5 | -11% |
| 2021 | $124.5 | $157.3 | +26% |
| 2022 | $157.3 | $131.3 | -17% |
| 2023 | $131.3 | $170.1 | +30% |
| 2024 | $170.1 | $241.2 | +42% |
| 2025 | $241.2 | $327.9 | +36% |
| 2026 YTD | $327.9 | $342.8 | +4.5% |
JPM has finished higher in four of the last six years. It's up 4.5% so far in 2026.
SPLS Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2016 | $9.62 | $9.22 | -4.2% |
| 2017 | $9.22 | $10.3 | +11% |
| 2026 YTD | $10.3 | $54.7 | +434% |
SPLS has the edge over JPM on returns for 2026, with the stronger performance.